ALLIANCES ::
Tissue Therapies Ltd is pursuing a collaborative business model using licensing and product sales/distribution to rapidly add shareholder value by embedding the VitroGro® technology in wound healing, burns & skin treatments and cell culture applications globally.
Tissue Therapies has a worldwide exclusive license to commercialise VitroGro® through an Intellectual Property License Agreement with Queensland University of Technology.
Investment Bank Orbit Capital (www.orbitcapital.com.au) is a corporate advisor to Tissue Therapies Ltd, and has been responsible for establishing the company, corporate structuring, capital raising and other commercial advice.
|
ALLIANCES